Condition
Granulomatosis With Polyangiitis (Wegener's) (GPA)
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Glucocorticoids Standard Dose
Research Leaders
6 sponsors active, led by University of Pennsylvania
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Glucocorticoids Standard Dose1
- No Plasma Exchange1
- Online Questionnaire1
- Plasma Exchange1
- Glucocorticoids Reduced Dose1
Active Sponsors
- University of Pennsylvania2
- University of Birmingham1
- University of Oxford1
- University of South Florida1
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Top Investigators
University of Pennsylvania
University of Oxford
Cambridge University Hospitals NHS Foundation Trust
McMaster University
University of Pennsylvania
Related Conditions
- Microscopic Polyangiitis Mpa2
- Eosinophilic Granulomatosis With Polyangiitis Churgstrauss Egpa1
- Churgstrauss Syndrome Css1
- Ancaassociated Vasculitis Aav1
- Vasculitis1